Takeda Pharmaceutical Co

Takeda Pharmaceutical Co - ADR TAK

Dividend Summary


The previous Takeda Pharmaceutical Co - ADR dividend was 31.91c and it went ex 9 months ago and it was paid 6 months ago.
There are typically 2 dividends per year (excluding specials).

Latest Dividends
Summary Previous dividend Next dividend
Status Paid
Type Interim
Per share 31.91c
Declaration date 13 Sep 2023 (Wed)
Ex-div date 28 Sep 2023 (Thu)
Pay date 11 Dec 2023 (Mon)

Enter the number of Takeda Pharmaceutical Co - ADR shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
99%
Our premium tools have predicted Takeda Pharmaceutical Co - ADR with 99% accuracy.
Dividend Yield Today
5.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Takeda Pharmaceutical Co - ADR
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Final 30 Mar 2029 USD Sign up
Forecast Interim 29 Sep 2028 USD Sign up
Forecast Final 31 Mar 2028 USD Sign up
Forecast Interim 30 Sep 2027 USD Sign up
Forecast Final 31 Mar 2027 USD Sign up
Forecast Interim 30 Sep 2026 USD Sign up
Forecast Final 31 Mar 2026 USD Sign up
Forecast Interim 30 Sep 2025 USD Sign up
Forecast Final 31 Mar 2025 USD Sign up
Forecast Interim 30 Sep 2024 USD Sign up
Declared Final 11 May 2023 28 Mar 2024 USD 31.05c 31.91c 😃
Paid Interim 13 Sep 2023 28 Sep 2023 11 Dec 2023 USD 31.91c
Paid Final 15 Mar 2023 30 Mar 2023 10 Jul 2023 USD 31c
Paid Interim 13 Sep 2022 29 Sep 2022 12 Dec 2022 USD 32.57c 32.96c 😃
Paid Final 04 Mar 2022 30 Mar 2022 11 Jul 2022 USD 33.01c
Paid Interim 29 Sep 2021 13 Dec 2021 USD 40.93c 40.93c 😄
Paid Final 15 Mar 2021 30 Mar 2021 12 Jul 2021 USD 40.66c
Paid Interim 29 Sep 2020 11 Dec 2020 USD 43.05c
Paid Final 30 Mar 2020 06 Jul 2020 USD 41.91c
Paid Interim 27 Sep 2019 12 Dec 2019 USD 41.11c
Paid Final 15 Mar 2019 28 Mar 2019 10 Jul 2019 USD 41.72c
Paid Interim 27 Sep 2018 13 Dec 2018 USD 39.55c
Paid Final 29 Jun 2018 28 Mar 2018 09 Jul 2018 USD 40.64c
Paid Interim 28 Sep 2017 11 Dec 2017 USD 39.95c
Paid Final 30 Mar 2017 10 Jul 2017 USD 39.89c
Paid Interim 29 Sep 2016 12 Dec 2016 USD 39.24c
Paid Final 15 Mar 2016 30 Mar 2016 11 Jul 2016 USD 43.71c
Paid Interim 14 Sep 2015 29 Sep 2015 11 Dec 2015 USD 36.53c
Paid Final 16 Mar 2015 30 Mar 2015 09 Jul 2015 USD 36.53c
Paid Interim 11 Sep 2014 26 Sep 2014 11 Dec 2014 USD 37.83c
Paid Final 13 Mar 2014 27 Mar 2014 10 Jul 2014 USD 44.37c
Paid Interim 26 Sep 2013 12 Dec 2013 USD 43.7c
Paid Final 27 Mar 2013 08 Jul 2013 USD 45.71c
Paid Interim 26 Sep 2012 13 Dec 2012 USD 54.6c
Paid Final 28 Mar 2012 09 Jul 2012 USD 56.38c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 56.38c
100%
2013 100.31c
77.9%
2014 88.07c
-12.2%
2015 74.36c
-15.6%
2016 80.24c
7.9%
2017 79.13c
-1.4%
2018 80.59c
1.8%
2019 81.27c
0.8%
2020 83.02c
2.2%
2021 83.71c
0.8%
2022 73.94c
-11.7%
2023 63.96c
-13.5%
2024 Sign Up Required
2025 Sign Up Required
2026 Sign Up Required
2027 Sign Up Required
2028 Sign Up Required
2029 Sign Up Required

Takeda Pharmaceutical Co Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
5.0%
Optimized Yield
Sign Up Required
52 Week High
6.7% on 25 March 2024
52 Week Low
4.2% on 28 September 2023
Next Ex-Div-Date Countdown
Sign Up Required

About Takeda Pharmaceutical Co

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Sector
Pharmaceuticals & Biotechnology
Country
United States
Share Price
$12.67 (yesterday's closing price)
Shares in Issue
3,165 million
Market Cap
$40.1bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
Other listings
Takeda Pharmaceutical Co
No articles found